Filter announcements
Loading...
Incorporated in 1978, Kilitch Drugs Ltd is engaged in the operation and management of Pharmaceutical Products
Kilitch Drugs (India) Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 27, 2026
Kilitch Drugs (India) Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 27, 2026
Kilitch Drugs (India) Limited has informed the Exchange about Copy of Newspaper Publication
Kilitch Drugs' board approved Q1 financial results. Consolidated Net Sales stood at ₹44.88 Cr, with Profit After Tax at ₹1.97 Cr. Basic EPS for the quarter was ₹0.83.